SyntheticMR AB (9480)
Market Open
12 Jun, 20:00
XSTU €
0. 05
+0.01
+30.8901%
€
- Market Cap
- P/E Ratio
- Div Yield
8,000 Volume
- Eps
€ 0.04
Previous Close Want to track 9480 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
9480 trading today higher at €0.05, an increase of 30.8901% from yesterday's close, completing a monthly increase of 4.1667% or €0. Over the past 12 months, 9480 stock lost -57.9832%.
9480 is not paying dividends to its shareholders.
SyntheticMR AB has completed 1 stock splits, with the recent split occurring on May 20, 2021.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
9480 Chart
SyntheticMR AB (9480) FAQ
What is the stock price today?
The current price is €0.05.
On which exchange is it traded?
SyntheticMR AB is listed on XSTU.
What is its stock symbol?
The ticker symbol is 9480.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has SyntheticMR AB ever had a stock split?
SyntheticMR AB had 1 splits and the recent split was on May 20, 2021.
SyntheticMR AB Profile
| Insurance Industry | Financials Sector | - CEO | XSTU Exchange | - ISIN |
| Sweden Country | 43 Employees | - Last Dividend | 20 May 2021 Last Split | - IPO Date |
Overview
SyntheticMR AB (publ), established in 2007 and based in Linköping, Sweden, is a pioneering company dedicated to enhancing the capabilities of magnetic resonance imaging (MRI). The company operates globally, with a presence in Sweden, the Middle East, Africa, Europe, North America, South America, and the Asia-Pacific region. SyntheticMR AB specializes in developing and marketing innovative imaging solutions that revolutionize how MRI scans are performed and interpreted. By leveraging advanced technologies, SyntheticMR AB aims to provide healthcare professionals with tools that deliver more informative, quantitative data and biomarker segmentations from MRI scans, facilitating accurate diagnoses and efficient patient follow-ups.
Products and Services
- SyMRI: This flagship product offers the ability to obtain multiple contrast images, biomarker segmentations, and quantitative data from a single MR sequence. This innovative approach enhances the efficiency of MRI scans, potentially reducing scanning time and making the process more comfortable for patients.
- SyMRI NEURO: Designed specifically for neurological applications, this product includes contrast-weighted images and biomarker segmentation. It also features volumetric measurements of brain tissues and parametric maps, providing objective decision support for diagnosing and monitoring various neurological conditions.
- SyMRI MSK: Tailored for musculoskeletal applications, SyMRI MSK is versatile across a range of anatomies. It provides quantitative T1, T2, and PD maps, alongside multiple contrast-weighted images. This allows for a comprehensive assessment of musculoskeletal health, aiding in the diagnosis and treatment planning of related disorders.
- MAGiC: A customer-specific version of SyMRI IMAGE, MAGiC is designed to cater to the unique needs of different healthcare providers. It leverages the core capabilities of SyMRI to deliver customized solutions, enhancing the flexibility and applicability of MRI imaging in various clinical settings.
- SyMRI Spine and SyMRI Knee: These applications are focused on delivering precise anatomical information from specific body parts using a single MRI sequence. They represent a significant advancement in the targeted assessment of spinal and knee conditions, respectively, offering detailed insights that can guide treatment decisions.
Contact Information
Address: Storgatan 11
Phone: 46 7 06 19 21 00
Website: https://www.syntheticmr.com
